Memorandum of Understanding With Duke University

---
identifier: "/us/fr/E9-22001"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Memorandum of Understanding With Duke University"
title_number: 0
title_name: "Federal Register"
section_number: "E9-22001"
section_name: "Memorandum of Understanding With Duke University"
positive_law: false
currency: "2009-09-14"
last_updated: "2009-09-14"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-22001"
document_type: "notice"
publication_date: "2009-09-14"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "74 FR 46998"
fr_volume: 74
docket_ids:
  - "Docket No. FDA-2009-N-0667"
  - "FDA 225-09-0010"
effective_date: "2009-08-04"
fr_action: "Notice."
---


#  Memorandum of Understanding With Duke University

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and Duke University. The purpose of this MOU is to establish a framework for collaboration between the Parties and for pursuing specific collaborative projects. This collaboration between the Parties shall be known as the Cardiac Safety Research Consortium.

**DATES:**

The agreement became effective August 4, 2009.

**FOR FURTHER INFORMATION CONTACT:**

Wendy R. Sanhai, Office of the Commissioner (HZ-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7867, FAX: 301-827-5891.

**SUPPLEMENTARY INFORMATION:**

In accordance with 21 CFR 20.108(c),  which states that all written agreements and MOUs between FDA and others shall be published in the *Federal Register* , the agency is publishing notice of this MOU.

Dated: August 31, 2009.

David Horowitz,

Assitant Commissioner for Policy.